22 July 2019 in BMC Infectious Diseases
Despite the greater sensitivity of the new dengue clinical classification proposed by the World Health Organization (WHO) in 2009, there is a need for a better definition of warning signs and clinical progression of dengue cases. Classic statistical methods have been used to evaluate risk criteria in dengue patients, however they usually cannot access the complexity of dengue clinical profiles. We propose the use of machine learning as an alternative tool to identify the possible characteristics that could be used to develop a risk criterion for severity in dengue patients. In this study, we analyzed the clinical profiles of 523 confirmed dengue cases using self-organizing maps (SOM) and random forest algorithms to identify clusters of patients with similar patterns. We identified four natural clusters, two with features of dengue without warning signs or mild disease, one that comprises the severe dengue cases and high frequency of warning signs, and another with intermediate characteristics. Age appeared as the key variable for splitting the data into these four clusters although warning signs such as abdominal pain or tenderness, clinical fluid accumulation, mucosal bleeding, lethargy, restlessness, liver enlargement and increased hematocrit associated with a decrease in platelet counts should also be considered to evaluate severity in dengue patients. These findings suggest that age must be the first characteristic to be considered in places where dengue is hyperendemic. Our results show that warning signs should be closely monitored, mainly in children. Further studies exploring these results in a longitudinal approach may help to understand the full spectrum of dengue clinical manifestations.
1 November 2024 in Journal of Comparative Effectiveness Research
Aim: To evaluate how transportability methods are currently used for real-world evidence (RWE) generation to inform good practices and support adoption and acceptance of these methods in the RWE context. Methods: We conducted a targeted literature review to identify studies that transported an effect estimate of the clinical effectiveness or safety of a biomedical exposure to a target real-world population. Records were identified from PubMed-indexed articles published any time before 25 July 2023 (inclusive). Two reviewers screened abstracts/titles and reviewed the full text of candidate studies to identify the final set of articles. Data on the therapeutic area, exposure(s), outcome(s), original and target populations and details of the transportability analysis (e.g., analytic method used, estimate transported, stated assumptions) were abstracted from each article. Results: Of 458 unique records identified, six were retained in the final review. Articles were published during 2021–2023, focused on the US/Canada context, and covered a range of therapeutic areas. Four studies transported an RCT effect estimate, while two transported effect estimates derived from real-world data. Almost all articles used weighting methods to transport estimates. Two studies discussed all transportability assumptions, and one evaluated the likelihood of meeting all assumptions and the impact of potential violations. Conclusion: The use of transportability methods for RWE generation is an emerging and promising area of research to address evidence gaps in settings with limited data and infrastructure. More transparent and rigorous reporting of methods, assumptions and limitations may increase the use and acceptability of transportability for producing robust evidence on treatment effectiveness and safety.
25 June 2024 in Pharmaceutical Statistics